Smartleaf Asset Management LLC Acquires 229 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

Smartleaf Asset Management LLC increased its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 178.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 357 shares of the company’s stock after acquiring an additional 229 shares during the period. Smartleaf Asset Management LLC’s holdings in Inspire Medical Systems were worth $66,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the business. First Horizon Advisors Inc. boosted its position in shares of Inspire Medical Systems by 885.7% in the 4th quarter. First Horizon Advisors Inc. now owns 138 shares of the company’s stock worth $26,000 after purchasing an additional 124 shares in the last quarter. True Wealth Design LLC purchased a new position in Inspire Medical Systems during the third quarter valued at $30,000. Farther Finance Advisors LLC boosted its holdings in Inspire Medical Systems by 1,158.3% in the third quarter. Farther Finance Advisors LLC now owns 151 shares of the company’s stock worth $32,000 after acquiring an additional 139 shares in the last quarter. Nisa Investment Advisors LLC boosted its holdings in Inspire Medical Systems by 37.3% in the fourth quarter. Nisa Investment Advisors LLC now owns 368 shares of the company’s stock worth $68,000 after acquiring an additional 100 shares in the last quarter. Finally, Quarry LP increased its holdings in shares of Inspire Medical Systems by 30.9% during the third quarter. Quarry LP now owns 449 shares of the company’s stock valued at $95,000 after acquiring an additional 106 shares in the last quarter. Institutional investors own 94.91% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. Robert W. Baird dropped their price target on shares of Inspire Medical Systems from $252.00 to $248.00 and set an “outperform” rating on the stock in a research note on Tuesday, February 11th. Wells Fargo & Company reduced their price target on shares of Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 11th. Bank of America upgraded shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $220.00 to $255.00 in a report on Wednesday, November 20th. KeyCorp reiterated an “overweight” rating and set a $234.00 target price (down from $236.00) on shares of Inspire Medical Systems in a research note on Friday, January 24th. Finally, Morgan Stanley decreased their price target on Inspire Medical Systems from $230.00 to $220.00 and set an “overweight” rating for the company in a research note on Tuesday, February 11th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, Inspire Medical Systems currently has an average rating of “Moderate Buy” and an average price target of $228.82.

Inspire Medical Systems Price Performance

INSP stock opened at $183.34 on Monday. The company has a market cap of $5.44 billion, a P/E ratio of 105.98, a price-to-earnings-growth ratio of 2.86 and a beta of 1.48. Inspire Medical Systems, Inc. has a 1 year low of $123.00 and a 1 year high of $257.40. The stock’s fifty day moving average price is $187.08 and its 200-day moving average price is $192.79.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Monday, February 10th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. As a group, analysts expect that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Insider Buying and Selling

In other Inspire Medical Systems news, CTO John Rondoni sold 583 shares of the business’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total transaction of $99,395.67. Following the completion of the sale, the chief technology officer now owns 10,424 shares of the company’s stock, valued at approximately $1,777,187.76. The trade was a 5.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Randy Ban sold 25,584 shares of the firm’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $183.50, for a total value of $4,694,664.00. Following the completion of the transaction, the insider now directly owns 7,259 shares in the company, valued at $1,332,026.50. This trade represents a 77.90 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 26,225 shares of company stock valued at $4,806,530. 4.10% of the stock is owned by insiders.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.